No abstract available.
Femur Neck* ; Fractures, Stress*

PURPOSE: An understanding of the immunological process is required if primary prevention of atopic diseases is to be developed in early childhood. But, it is too hard to distinguish atopy from nonatopy under the age of two clinically, because the expression of phenotype and cytokines is vague in early childhood. We evaluated DNA methylation changes at Th2 interleukin-4 gene in peripheral blood from atopic children. METHODS: We selected 15 allergic children (mild: eight, moderate to severe: seven) and seven normal controls by using family allergy scores and clinical histories. We measured Total IgE and Der f II specific IgE levels and cultured peripheral blood mononuclear cells with Der f II stimulation and extracted DNA from Der f II specific T cells. We examined the change of CpG methylation in DNA from atopic and nonatopic children. RESULTS: In T cells from normal children, IL-4 DNA were predominantly methylated; otherwise, CpG demethylation occurred in Der f II specific T cells from allergic children. CONCLUSION: IL-4 DNA methylation changes occurred in T genes from allergic children and DNA methylation assay in early childhood.
Child* ; Cytokines ; DNA Methylation* ; DNA* ; Humans ; Hypersensitivity ; Immunoglobulin E ; Interleukin-4* ; Methylation ; Phenotype ; Primary Prevention ; T-Lymphocytes

BACKGROUND AND OBJECTIVES: Galectin-3 is a beta-galactoside binding protein that has been reported to be implicated in numerous biologic and pathologic functions including cell growth, cell adhesion, inflammation, neoplastic transformation, and apoptosis. Most previous studies in thyroid tissue have found galectin-3 expression to be a feature of malignant and not of benign or normal tissue. The aim of this study was to investigate the expression of galectin-3 in 57 thyroid lesions, to assess its potential as a marker in the diagnosis and classification of thyroid malignancy. SUBJECTS AND METHOD: The followings were studied: 19 cases of papillary carcinomas, 8 of follicular carcinomas, one anaplastic carcinoma, one medullary carcinoma, 16 follicular adenomas, and 12 nodular hyperplasia. Formalin-fixed paraffin-embedded thyroid tissues were stained immunohistochemically for galectin-3. RESULTS: Galectin-3 expression was found in all cases, however, it was strong in papillary carcinomas than in follicular carcinomas or adenomas. In nodular hyperplasia, galectin-3 expression was very weak and focal. A significant difference was not found in the expression of galectin-3 between follicular carcinomas and follicular adenomas. CONCLUSION: Galectin-3 is a reliable marker of papillary carcinoma but not useful in identifying follicular carcinoma.
Adenoma ; Apoptosis ; Carcinoma ; Carcinoma, Medullary ; Carcinoma, Papillary ; Carrier Proteins ; Cell Adhesion ; Classification ; Diagnosis ; Galectin 3* ; Hyperplasia ; Immunohistochemistry ; Inflammation ; Thyroid Gland*